NCM
Nantahala Capital Management Portfolio holdings
AUM
$1.41B
This Quarter Return
+10.08%
1 Year Return
+32.9%
3 Year Return
+104.34%
5 Year Return
+145.08%
10 Year Return
+443.66%
AUM
$1.04B
AUM Growth
+$1.04B
(-5.8%)
Cap. Flow
-$119M
Cap. Flow
% of AUM
-11.45%
Top 10 Holdings %
Top 10 Hldgs %
51.31%
Holding
129
New
18
Increased
29
Reduced
40
Closed
12
Top Buys
| 1 |
uniQure
QURE
|
$7.45M |
| 2 |
CVT
Cvent Holding Corp. Common Stock
CVT
|
$7.06M |
| 3 |
APEN
Apollo Endosurgery, Inc.
APEN
|
$5.14M |
| 4 |
IMAX
IMAX
|
$4.93M |
| 5 |
America's Car Mart
CRMT
|
$3.89M |
Top Sells
Sector Composition
| 1 | Healthcare | 48.06% |
| 2 | Consumer Discretionary | 17.92% |
| 3 | Communication Services | 8.18% |
| 4 | Financials | 6.75% |
| 5 | Industrials | 6.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
United Therapeutics
UTHR
$17.5B
| $3.52M | 0.27% |
+15,700
| New | +$3.52M |
|
52
IDEAYA Biosciences
IDYA
$2.26B
| $3.48M | 0.27% |
253,480
| – | – |
|
53
Viking Therapeutics
VKTX
$3.1B
| $3.34M | 0.26% |
+200,700
| New | +$3.34M |
|
|
APTO
54
DELISTED
Aptose Biosciences, Inc.
APTO
| $3.19M | 0.24% |
4,978,975
-1,073,892
| -18% | -$687K |
|
55
Medifast
MED
$153M
| $3.11M | 0.24% |
30,000
| – | – |
|
56
Jasper Therapeutics
JSPR
$45M
| $3.06M | 0.23% |
+1,688,454
| New | +$3.06M |
|
|
OPTN
57
DELISTED
OptiNose
OPTN
| $2.8M | 0.21% |
1,450,000
| – | – |
|
|
AAN
58
DELISTED
The Aaron's Company, Inc.
AAN
| $2.79M | 0.21% |
288,572
| – | – |
|
59
TELA Bio
TELA
$67M
| $2.72M | 0.21% |
256,092
-92,910
| -27% | -$989K |
|
60
Enova International
ENVA
$3.01B
| $2.37M | 0.18% |
53,250
| – | – |
|
|
MACK
61
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
| $2.35M | 0.18% |
191,266
-18,734
| -9% | -$230K |
|
62
Scully Royalty
SRL
$77.4M
| $2.08M | 0.16% |
310,522
-5,488
| -2% | -$36.8K |
|
63
Dyne Therapeutics
DYN
$1.91B
| $2.06M | 0.16% |
+178,901
| New | +$2.06M |
|
64
Neuropace
NPCE
$296M
| $1.98M | 0.15% |
425,925
-7,657
| -2% | -$35.5K |
|
|
JBIO
65
Jade Biosciences, Inc. Common Stock
JBIO
$251M
| $1.92M | 0.15% |
95,000
+79,300
| +505% | +$1.6M |
|
66
Disc Medicine
IRON
$2.2B
| $1.9M | 0.15% |
89,538
-73,224
| -45% | -$1.55M |
|
67
B. Riley Financial
RILY
$167M
| $1.77M | 0.14% |
62,520
-5,776
| -8% | -$164K |
|
68
Daktronics
DAKT
$847M
| $1.66M | 0.13% |
292,187
| – | – |
|
69
ADC Therapeutics
ADCT
$354M
| $1.64M | 0.13% |
840,000
+596,710
| +245% | +$1.16M |
|
70
Soleno Therapeutics
SLNO
$3.56B
| $1.5M | 0.11% |
699,364
+95,185
| +16% | +$204K |
|
71
Anebulo Pharmaceuticals
ANEB
$101M
| $1.48M | 0.11% |
511,073
| – | – |
|
72
Rezolute
RZLT
$623M
| $1.48M | 0.11% |
769,606
+50,870
| +7% | +$97.7K |
|
|
IMTXW
73
DELISTED
Immatics N.V. Warrants
IMTXW
| $1.42M | 0.11% |
986,101
| – | – |
|
74
Avalo Therapeutics
AVTX
$141M
| $1.42M | 0.11% |
808,844
+268,177
| +50% | +$469K |
|
75
Cartesian Therapeutics
RNAC
$265M
| $1.39M | 0.11% |
+1,000,000
| New | +$1.39M |
|